National Trends in Per Capita Pharmaceutical Spending, 1980–2015

Slides:

Advertisements

Similar presentations

THE COMMONWEALTH FUND Multinational Comparisons of Health Systems Data, 2013 David Squires The Commonwealth Fund November 2013.

Advertisements

Peterson-Kaiser Health System Tracker What is behind the recent slowdown in health spending?

“If We Are So Good... Why Aren’t We Better?” A Critical and Quick View of the U.S. Health Care System Forces of Change - Fall 2010 Eric D. Kupferberg,

Facts and Figures 2008 Medicines and Health Care The Norwegian Association of Pharmaceutical Manufacturers (LMI)

Exhibit 25.1 Annual Percentage Changes in the Prescription Drug Price Index and Prescription Drug Expenditures, Copyright 2011 Health Administration.

Notes: GDP refers to gross domestic product. Dutch and Swiss data are for current spending only, and exclude spending on capital formation of health care.

THE COMMONWEALTH FUND Cost-Related Access Problems Among the Chronically Ill, in Eight Countries, 2008 Base: Adults with any chronic condition Percent.

Economic Growth Growth in National Income. Economic growth – growth in national income Economic growth means an increase in national income – the economy.

Top quintile (61 local areas) Second quintile (61) Third quintile (63) Fourth quintile (61) Overall performance, 2016 Bottom quintile (60) Source: Commonwealth.

Robin Osborn and David Squires

Economics of Pharmaceutical Regulation in the Mediterranean: the case of Spain and Italy Joan Costa Font LSE.

THE COMMONWEALTH FUND Oceans Apart: The Higher Health Costs of Women in the U.S. Compared to Other Nations, and How Reform Is Helping Ruth Robertson, M.Sc.

Percent of Medicare population

Roberto ASTOLFI and Luca LORENZONI

Multinational Comparisons of Health Systems Data, 2011

Mirror, Mirror on the Wall: How the Performance of the U. S

Medicare Household Spending Non-Medicare Household Spending

Health Care Spending as a Percentage of GDP, 1980–2014

More Than One-Quarter of Insured Adults Were Underinsured in 2016

How Canada Compares Internationally

embargoed until 12:01 A.M Nov 15, 2012 Teleconference Chart Pack

Media Teleconference November 14, 2017 Robin Osborn

The U.S. Health Care System: An International Perspective

Public opinion on prescription drugs and their prices

Whole Washington Better healthcare for less

Senior Vice President, The Commonwealth Fund

Uninsured Adults and Those with Coverage Gaps Reported Medical Bill Problems at Higher Rates Than Did Those Continuously Insured, 2016 Percent of adults.

Uninsured Adults and Those with Coverage Gaps Reported Cost-Related Access Problems at Higher Rates Than Did Those Continuously Insured Percent of adults.

Mirror Mirror Teleconference

Commonwealth Fund 2016 International Health Policy Survey of Adults in 11 Countries Robin Osborn Media Teleconference November 15, 2016.

Public opinion on prescription drugs and their prices

Survey of adults age 18 and older in eleven countries.

Fewer Women Say They Are Not Getting Needed Care Because of Costs

Across Income Groups, Increasing Numbers of U. S

Women in the U.S. Report Highest Rates of Not Getting Needed Care Because of Cost Percent of women ages 19–64 who experienced any access problem because.

Percent adults ages 19–64 insured all year who were underinsured*

Educational Teleconference

The Commonwealth Fund 2014 International Health Policy Survey of Older Adults in Eleven Countries EMBARGOED UNTIL 4:00 P.M. ET, NOV. 19, 2014 Robin Osborn.

State of health care in the US

Sara R. Collins, Ph.D. Assistant Vice President The Commonwealth Fund

Percent of adults ages 19– In the past 12 months:

Financial Incentives and Targeted Support

What is behind the recent slowdown in health spending?

Vice President, Health Care Coverage and Access

Public opinion on prescription drugs and their prices

Multinational Comparisons of Health Systems Data, 2018

The Gini index is a measure of income inequality — the higher the coefficient, the greater the inequality. Among the select OECD countries,1 Canada has.

Deductibles Have Become a Growing Factor in Underinsurance Rates

2017 Commonwealth Fund International Symposium

High Chronic Disease Burden Among U.S. Women

More Than One-Third of Women in the U. S. Skip Care Because of Cost vs

2008 Survey Profile of Sicker Adults with Any Chronic Condition

Inadequate Coverage Is Associated with More Cost-Related Problems Getting Needed Care Percent of adults ages 19–64 who had any of four access problems.

Medical Bill Problems or Medical Debt

Adults Ages 19–64 Who Are Uninsured and Underinsured, by Poverty Status, 2003 *Underinsured defined as insured all year but experienced one of the following:

The Number of Underinsured Adults Under Age 65 Rose to 25 Million in 2007, Up from 16 Million in 2003 Percent of adults ages 19– Total.

Percent of adults (ages 19–64)

Premium tax credits have made the cost of marketplace plans similar to employer plans for low-income adults, but adults with higher incomes pay more Percent.

Patient Engagement in Care Management for Chronic Condition

Uninsured during the year

Exhibit ES-1. Overall Ranking

The Share of Women Spending 10 Percent or More of Their Income on Health Care Climbed over the Past Decade, Especially for Women with Low Incomes Percent.

Households with employer coverage can spend thousands of dollars on premiums and out-of-pocket costs. Distribution of spending on premiums and out-of-pocket.

Experiences with Prescription Drugs in Past Two Years

When Low-Income Adults Have a Medical Home and Insurance, Their Rates of Having Cost-Related Access Problems Decline Percent of adults ages 19–64 with.

Percent of adults (ages 19–64)

Under the Affordable Care Act, Young Adults Will Benefit from Newly Subsidized Sources of Health Insurance Percent of young adults ages 19–29 Total

Percent adults insured all year ages 19–64 who were underinsured*

The Number of Adults Reporting Not Getting Needed Care Because of Cost Declined in 2014 for the First Time Since 2003 Percent of adults ages 19–

Health Care Policy.

Presentation transcript:

National Trends in Per Capita Pharmaceutical Spending, 1980–2015 Exhibit 1 National Trends in Per Capita Pharmaceutical Spending, 1980–2015 Notes: Final expenditure on pharmaceuticals includes wholesale and retail margins and value-added tax. Total pharmaceutical spending refers in most countries to “net” spending, i.e., adjusted for possible rebates payable by manufacturers, wholesalers, or pharmacies. Data from all countries include only the portion spent on retail prescription medications, except for the Netherlands and the United Kingdom, where spending on pharmaceuticals includes prescribed medicines, over-the-counter medications, and other medical nondurable goods. Pharmaceuticals consumed in hospitals and other health care settings are excluded. Data: Organisation for Economic Co-operation and Development, 2017. Data for Australia and Canada from 2014.

Retail Pharmaceutical Spending, 2015 Exhibit 2 Retail Pharmaceutical Spending, 2015 Notes: Final expenditure on pharmaceuticals includes wholesale and retail margins and value-added tax. Total pharmaceutical spending refers in most countries to “net” spending, i.e., adjusted for possible rebates payable by manufacturers, wholesalers, or pharmacies. Data from all countries include only the portion spent on retail prescription medications, except for the Netherlands and the United Kingdom, where spending on pharmaceuticals includes prescribed medicines, over-the-counter medications, and other medical nondurable goods. Pharmaceuticals consumed in hospitals and other health care settings are excluded. All health care spending estimates exclude capital formation. Data: Organisation for Economic Co-operation and Development, 2017.

Share of Generics in Pharmaceutical Markets Exhibit 3 Share of Generics in Pharmaceutical Markets Percent Notes: Data not available for Sweden. Data represent the total pharmaceutical market in Canada, Norway, and Switzerland. Data represent the reimbursed pharmaceutical market in Australia, France, Germany, the Netherlands, and the United Kingdom. Data represent the community pharmacy market in the United States. Data from 2014 in all countries except in Canada and France (2013), the U.S. (2012) and Australia (2007). Data: Organisation for Economic Co-operation and Development, 2016.

Retail Price Index for Pharmaceuticals, 2010 Exhibit 4 Retail Price Index for Pharmaceuticals, 2010 CAN 50 UK 46 GER 95 FRA 61 US 100 SWIZ 88 AUS 49 Notes: Data not available for the Netherlands, Norway, or Sweden. Weighting is based on a Laspeyres index. See Kanavos et al. 2013 for further details. Data: P. Kanavos, A. Ferrario, S. Vandoros et al., “Higher U.S. Branded Drug Prices and Spending Compared to Other Countries May Stem Partly from Quick Uptake of New Drugs.” Health Affairs, April 2013 32(4):753–61.

Monthly Price of Six Top-Selling Prescription Drugs Exhibit 5 Monthly Price of Six Top-Selling Prescription Drugs Average U.S. discount Note: Data not available for the Netherlands, Norway, or Sweden, nor for Australia in the case of Sovaldi. Data: R. Langreth, B. Migliozzi, and K. Gokhale, The U.S. Pays a Lot More for Top Drugs Than Other Countries (Bloomberg, Dec. 18, 2015).

Exhibit 6 Adults Who Cited Cost as a Reason for Skipping Prescriptions or Doses, 2016 Percent Data: 2016 Commonwealth Fund International Health Policy Survey of Adults in 11 Countries.

Exhibit 7 Adults Who Cited Cost as a Reason for Skipping Prescriptions or Doses, by Health Status, 2016 Percent Data: 2016 Commonwealth Fund International Health Policy Survey of Adults in 11 Countries.

Exhibit 8 Low-Income U.S. Adults Who Cited Cost as a Reason for Skipping Prescriptions or Doses, 2003–2016 Percent Note: Population limited to adults ages 19 to 64 and with household poverty status at 200% of federal poverty level or lower. Data: The Commonwealth Fund Biennial Health Insurance Surveys (2003, 2005, 2007, 2010, 2012, 2014, 2016).